课题基金 / 基金详情

CLINICAL ASSESSMENT OF TUMOR HYPOXIA WITH PET

CLINICAL ASSESSMENT OF TUMOR HYPOXIA WITH PET
PET 肿瘤缺氧的临床评估
批准号:
6173963
负责人:
FARROKH DEHDASHTI
金额:
$15.35万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-04-05 至 2003-03-31

项目成果

FARROKH DEHDASHTI的其他基金

相似基金

相关文献

期刊论文(9)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1513/pats.200507-075ds
发表时间: 2005-01-01
期刊: Proceedings of the American Thoracic Society
影响因子: --
作者: [Chen, Delphine L, Dehdashti, Farrokh]
通讯作者: Dehdashti, Farrokh
Assessing tumor hypoxia by positron emission tomography with Cu-ATSM.
通过 Cu-ATSM 正电子发射断层扫描评估肿瘤缺氧。
DOI: --
发表时间: 2009
期刊: The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...
影响因子: --
作者: [Holland,JP, Lewis,JS, Dehdashti,F]
通讯作者: Dehdashti,F
FFNP-PET as a predictive biomarker of response to endocrine therapy approaches in advanced breast cancer
  • 批准号:
    10504739
  • 项目类别:
  • 资助金额:
    $64.72万
  • 财政年份:
    2022
  • 负责人:
    FARROKH DEHDASHTI
  • 依托单位:
Novel CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy
  • 批准号:
    10534151
  • 项目类别:
  • 资助金额:
    $16.85万
  • 财政年份:
    2019
  • 负责人:
    FARROKH DEHDASHTI
  • 依托单位:
Novel CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy
  • 批准号:
    10318589
  • 项目类别:
  • 资助金额:
    $59.19万
  • 财政年份:
    2019
  • 负责人:
    FARROKH DEHDASHTI
  • 依托单位:
Novel CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy
  • 批准号:
    10078604
  • 项目类别:
  • 资助金额:
    $59.73万
  • 财政年份:
    2019
  • 负责人:
    FARROKH DEHDASHTI
  • 依托单位:
海外基金